GH secretagogue activity
Ipamorelin stimulated GH release in cellular and animal experiments; endocrine selectivity in swine is not proof of human safety.
Raun et al., 1998 →Secretagogue pentapeptide
Ipamorelin is a pentapeptide investigated as a growth hormone secretagogue in pituitary-cell assays and animal models.

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms
Mixed · Study formulation · Rat pituitary cells, rats and swine
Ipamorelin stimulated GH release in cellular and animal experiments; endocrine selectivity in swine is not proof of human safety.
Raun et al., 1998 →Literature findings; refer to the model and formulation studied.
Ipamorelin — secretagogue pentapeptide. The literature identity must be matched to the documented chemical form and composition of the supplied material.
GHRP and GHRH antagonists were used to distinguish the GH-release pathway. Experiments indicated action through a GHRP-like receptor, with potency evaluated in pituitary cells and animals. Hormonal selectivity observed in swine belongs to that model.
Rat pituitary cells, rats and swine
Ipamorelin stimulated GH release in cellular and animal experiments; endocrine selectivity in swine is not proof of human safety.
Evidence concerns the studied material and model, not the supplied BLOPEP batch.
Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH · 1998 · European journal of endocrinology
DOI: 10.1530/eje.0.1390552Nominal variant content; analytical results belong to the documented batch.
Review specifications, analytical results and documentation for published batches.
Batch results have not yet been published on this page.
Consult the specific conditions in the supplied material documentation.
Freight, timing and import terms will be confirmed in the quote for the selected destination.